Tonix Pharmaceuticals Holding (TNXP) Retained Earnings (2023 - 2025)
Historic Retained Earnings for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to -$807.8 million.
- Tonix Pharmaceuticals Holding's Retained Earnings fell 1400.24% to -$807.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$807.8 million, marking a year-over-year decrease of 1400.24%. This contributed to the annual value of -$730.7 million for FY2024, which is 2164.89% down from last year.
- Per Tonix Pharmaceuticals Holding's latest filing, its Retained Earnings stood at -$807.8 million for Q3 2025, which was down 1400.24% from -$775.8 million recorded in Q2 2025.
- In the past 5 years, Tonix Pharmaceuticals Holding's Retained Earnings ranged from a high of -$517.0 million in Q1 2023 and a low of -$807.8 million during Q3 2025
- Over the past 3 years, Tonix Pharmaceuticals Holding's median Retained Earnings value was -$694.4 million (recorded in 2024), while the average stood at -$665.2 million.
- Its Retained Earnings has fluctuated over the past 5 years, first crashed by 2732.36% in 2024, then tumbled by 1172.6% in 2025.
- Over the past 3 years, Tonix Pharmaceuticals Holding's Retained Earnings (Quarter) stood at -$600.7 million in 2023, then fell by 21.65% to -$730.7 million in 2024, then decreased by 10.55% to -$807.8 million in 2025.
- Its Retained Earnings was -$807.8 million in Q3 2025, compared to -$775.8 million in Q2 2025 and -$747.5 million in Q1 2025.